InflaRx (IFRX) Non-Current Deffered Revenue (2017 - 2019)
InflaRx's (IFRX) quarterly Non-Current Deffered Revenue came in at $8950.8 in Q3 2019, down 11.49% quarter-over-quarter from $10112.8 in Q2 2019.
Analysis
InflaRx (IFRX) Non-Current Deffered Revenue (2017 - 2019) Analysis & Trends
InflaRx has disclosed Non-Current Deffered Revenue across 3 years of filings, most recently posting $8950.8 for Q3 2019.
- In Q3 2019, Non-Current Deffered Revenue changed N/A year-over-year to $8950.8; the TTM figure through Sep 2019 stood at $8950.8 (changed N/A YoY), while the FY2018 annual figure was $12754.8, down 24.71% from the prior year.
- Non-Current Deffered Revenue came in at $8950.8 for Q3 2019 at InflaRx, down from $10112.8 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $17661.5 in Q4 2017 to a low of $8950.8 in Q3 2019.
- Average Non-Current Deffered Revenue over 3 years is $12083.0, with a median of $11366.3 recorded in 2019.
- The largest YoY upside for Non-Current Deffered Revenue was 30.22% in 2018 against a maximum downside of 30.22% in 2018.
- Over 3 years, Non-Current Deffered Revenue stood at $17661.5 in 2017, then sank by 30.22% to $12323.7 in 2018, then declined by 27.37% to $8950.8 in 2019.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $8950.8 in Q3 2019, $10112.8 in Q2 2019, and $11366.3 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 220.40 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 147.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 8,950.80 |
| Jun 30, 2019 | 10,112.75 |
| Mar 31, 2019 | 11,366.29 |
| Dec 31, 2018 | 12,323.66 |
| Dec 31, 2017 | 17,661.49 |